CTLA4 and neoplasm: Using flow cytometry, we tested for the presence of anti-tumor antibody in these serum specimens and observed the fold change in MFI of anti-tumor antibodies was significantly higher in RT + IT-IC + anti-CTLA-4 treated mice compared those cured by surgical resection (n = 7–8; p = 0.0401) (Figure 1E).